Silo Wellness To Acquire Canadian Dyscovry Science, Producer Of Psilocybin For IBS Treatment
Shrooms are known to cause nausea, so you wouldn’t expect them to help with digestive issues.
However, the Toronto-based startup Dyscovry Science Ltd. is developing a synthetic psilocybin formulation to target irritable bowel syndrome (IBS). Psilocybin’s anti-inflammatory effect may help with the disorder.
The preliminary research must be promising because Silo Wellness (SILO) just entered into an agreement to acquire 100% of Dyscovry Science.